Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07692321

Co-designing Enhanced Models of Care for First Nations Children at Risk for Childhood-onset Type 2 Diabetes

The overall objective: to co-design and implement targeted and timely community led strategies to improve the health of the Next Generation and end the intergenerational impact of T2D in this population.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Guided by gaps in knowledge and care identified by participant advisors, community, and First Nations leadership, the investigators have developed a multifaceted and multidisciplinary research program which leverages the existing NextGen Cohort to enhance metabolic screening and evaluate novel intervention strategies. With First Nations partners the investigators will 1) Co-develop a perinatal support program led by a community-based navigator to support maternal and early childhood nutrition and activity, including breastfeeding supports, aimed at diabetes prevention, 2) Implement community-based early childhood screening for evidence of dysglycemia, and 3) Co-develop and implement a community led land-based program for children ages 4-5 years and their caregivers to encourage and educate about the benefits of traditional nutrition and activities to maintain wellness. In partnership with the Four Arrows Regional Health Authority (FARHA) and its four governing Anisininew First Nations in Manitoba, this program of research will address the lifecycle of intergenerational T2D by implementation of pre and post-natal/early childhood interventions in a population with the highest rates of childhood-onset T2D observed in the world.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for the breastfeeding program:

  • Pregnant women with type 2 diabetes or no diabetes.
  • From self-identified Indigenous heritage (e.g., Cree, Oji-Cree, Métis, Anishinaabe, etc.) residing in the four Anisininew communities in the Island Lake region.
  • Are delivering in Manitoba.
  • Mother/Father and children must be biological family members.

Exclusion criteria

from the breastfeeding program:

  • Parents or children with type 1 diabetes.
  • Residing outside of Manitoba.

Inclusion criteria

for the CGM pro

Treatment and study plan

Breastfeeding and perinatal education and support

Behavioral

Co-develop and implement a community-based perinatal education and support program using navigators to support breast feeding, maternal nutrition and activity, and early infancy/childhood nutrition and activity.

Purchasing HbA1c machines for communities

Device

This will allow study participants to conduct earlier and more frequent screening for early dysglycemia, prediabetes and T2D.

Continuous glucose monitoring

Device

We will investigate the use of continuous glucose monitoring (CGM) to detect early dysglycemia in the Next Gen cohort.

Land-based Wellness Programming

Behavioral

Co-develop and implement community led land-based programming for parent(s) and preschool children aged 4-5 years to encourage traditional nutrition and activities to maintain wellness.

Primary outcomes

  1. Proportion of mothers who initiate breastfeeding

    Time frame: 3 years

    This will be for for both groups experiencing and not experiencing diabetes during the pregnancy, exclusivity of breastfeeding and breastfeeding continuation at 1, 3 and 6 months. In addition, we will examine the growth trajectories of infants who are breastfed and compare them to infants who are not breastfed (from historical NextGen Cohort follow up and the current project).

  2. Number of eligible children in the NextGen Cohort screened per community

    Time frame: 3 years

    This is a feasibility pilot to determine if participants will be screened more frequently once there are point of care HbA1C machines in each community.

    Qualitative data on the feasibility and implementation of the screening program via interviews with the community health care workers and NextGen families to determine facilitators and barriers to screening in community and areas of improvement for the program.

  3. Percentage of sensor time with glucose > 7.8 mmol/L

    Time frame: 3 years

    This is to determine the feasibility of using CGM with 6 and 7 year old children. SD of sensor glucose levels (a summary measure of glycemic variability - amplitude, frequency and duration of fluctuation in glucose measurement) and 2. tolerability and feasibility of CGM use in this population.

  4. Number of times the land-based wellness program ran

    Time frame: 3 years

    Feasibility of establishing and implementing this program will be assessed by metrics including how often the program ran (bench marked against number of sessions planned), and number of children participating (benchmarked against number eligible).

  5. Number of children who attend the land-based wellness programming

    Time frame: 3 years

  6. Number of young adult leaders hired for the land-based wellness program

    Time frame: 3 years

    We anticipate that another key outcome will be capacity building for young adult leaders who will work alongside Elders and develop skills in leadership, youth health and wellness, program evaluation, and land-based curriculum development

Secondary outcomes

  1. Number of mothers who enroll and participate in the breastfeeding navigator-based program

    Time frame: 3 years

  2. Number classes attended by mothers who participate in the breastfeeding navigator-based program

    Time frame: 3 years

  3. Qualitative review of the land-based wellness program

    Time frame: 3 years

    Barriers and facilitators of program success will be co-determined by Anisininew leaders through the evaluative process, and may include qualitative interviews with family participants and leaders and/or sharing circles lead by Elders and Knowledge keepers.

Study contacts

Contact information is provided by the study sponsor or research team.

Brandy A Wicklow, MD, MSc

CONTACT

[email protected]

204-787-1222

Elizabeth AC Sellers, MD, MSc

CONTACT

[email protected]

204-787-3011

Sponsors and collaborators

Lead sponsor

University of Manitoba

Other

Collaborators

  • Canadian Institutes of Health Research (CIHR)
  • Children's Hospital Research Institute of Manitoba

Registry information

Official study title

Co-designing Enhanced Models of Care for First Nations Children at Risk for Childhood-onset Type 2 Diabetes: The Next Generation Birth Cohort.

Important dates

Study start
2026
Primary completion
2030
Study completion
2031
First posted
Jul 9, 2026
Registry last updated
Aug 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.